Albuterol Sulfate
Product Images NDC 68071-5206

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 68071-5206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5206 2)

This is a description of an asthma medication by NuCare Pharmaceuticals, Inc. The medication, which is only available by prescription, comes in the form of a metered inhaler with each actuation delivering 108mcg Albuterol Sulfate, equivalent to 90mcg Albuterol. The lot number for this medication is 000000. The manufacturer's NDC code is 45802-088-01 and the product's NDC code is 68071-5206-02. The medication should be kept at a controlled temperature of 68-77°F and out of reach of children. This information is not intended to be a full list of ingredients.*

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure-a-b.jpg (Figure A B)

The scanned document appears to be an image and not text. It is not readable.*

FDA Label Image

Figure-c.jpg (Figure C)

FDA Label Image

Figure-d.jpg (Figure D)

Albuterol Sulfate Inhalation Aerosol is a medication for inhalation that comes with 200 sprays for use and 3 additional sprays for priming purposes. This figure D shows that before priming the device, the spray counter will read 200 and after priming, it will read 203.*

FDA Label Image

Figure-e.jpg (Figure E)

FDA Label Image

Figure-f.jpg (Figure F)

FDA Label Image

Figure-g-h.jpg (Figure G H)

FDA Label Image

Figure-graphs (Figure Graphs)

This is a chart showing the percentage change in FEV over time in a clinical trial that lasted for 6 weeks. The trial included three groups: one group using albuterol sulfate inhalation aerosol, one group using a matched placebo HFA inhalation aerosol, and one group using a marketed HFA-134a albuterol inhaler. The chart shows the percentage change in FEV on Day 1 and Day 43.*

FDA Label Image

Figure-i.jpg (Figure I)

FDA Label Image

Figure-j.jpg (Figure J)

FDA Label Image

Figure-k.jpg (Figure K)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.